Greatview Aseptic Packaging (468) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
26 Aug, 2026Executive summary
Revenue for the six months ended 30 June 2026 declined by 14.5% year-over-year to RMB861.0 million, with net profit plunging 91.7% to RMB6.9 million due to lower gross margin, loss of international business consolidation, and higher administrative expenses.
PRC segment revenue fell 1.8% mainly from lower average sales prices and reduced filling machine revenue, while international segment revenue dropped 52.3% due to lower sales volume and prices.
Gross margin decreased to 14.3% from 16.1% year-over-year, and net profit margin dropped to 0.8% from 8.2%.
Financial highlights
Gross profit fell 24.2% to RMB122.8 million; other income decreased 45.8% to RMB14.8 million.
Administrative expenses rose 30% to RMB102.6 million, while selling and distribution expenses decreased 24.8% to RMB24.6 million.
Cash and cash equivalents stood at RMB211.3 million as of 30 June 2026, down from RMB461.7 million at year-end 2025.
No interim dividend was declared for the period.
Outlook and guidance
The company plans to deepen digital transformation, strengthen supply chain resilience, and focus on sustainable development.
Strategic priorities include expanding PRC market share, steady international growth, technological innovation, and enhanced ESG practices.
Latest events from Greatview Aseptic Packaging
- Sharp profit decline, restructuring, and internal control issues drive major remedial actions.468
H2 2025 - Net profit fell 32.4% on lower margins; trading remains suspended after major shareholding change.468
H1 2025 - Revenue and profit plunged amid governance overhaul, investigations, and trading suspension.468
H2 2024 - Net profit rose 17.7% despite a 13.9% revenue drop, amid restructuring and takeover activity.468
H1 2024